All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...704Next →

hiv & aids news selected from other sources

  • Hepatitis C treatment
    Hepatitis C: Sit in of European patients to request access to new medicines, on occasion of the informal meeting of European Health Ministers in Milan
    EATG | 15 hours ago

    In support of the Call to EU Ministers of Health and CEOs of Abbvie, BMS, Gilead, Janssen and Merck/MSD regarding Universal Access to Curative Hepatitis C Treatment in the EU an beyond (attached), EPAC, Lila and Nadir with the support of the subscribers of the call, organized a “Sit-In” of people living with hepatitis C and their allies on the 22nd of September, at the Mico Conference Center, in Milan, starting at 11:20 am, to advocate for, and demand, a clear political and public health commitment and leadership from the twenty eight member states of the European Union

  • Kidney problems
    Guidelines Advise Against Tenofovir for HIV Patients With Kidney Disease
    The Body Pro | 21 hours ago

    HIV-positive patients who have reduced kidney function should take antiretroviral therapy, but should avoid regimens that contain tenofovir (Viread), according to updated treatment guidelines from the HIV Medicine Association (HIVMA).

  • Ageing and HIV
    The First HIV/AIDS Generation Reaches Retirement Age
    Newsweek | 21 hours ago

    People with HIV and AIDS are living longer than was ever expected before the development of highly active antiretroviral therapies in the 1990s. Palm Springs, a Coachella Valley desert city 100 miles east of Los Angeles, has become a hub for older infected residents well into their 60s and 70s. Yet even as many live longer, there is a broad segment of HIV patients who are aging physically and cognitively faster than the rest of the population.

  • Hepatitis C treatment
    The new $84,000 hepatitis C treatment is losing momentum, for now
    Washington Post | 22 hours ago

    Data released by CVS Health on Tuesday show that use of Sovaldi has slowed down since May after the drug's record-setting start last December. The slowdown can partly be explained by the health-care industry's anticipation of more hepatitis C treatments soon hitting the market, including another one from Gilead that could gain FDA approval any day now.

  • PrEP
    Prep Use Up in SF, Advocates Seek Wider Access
    BETA blog | 22 hours ago

    The number of people using pre-exposure prophylaxis, or PrEP, to prevent HIV infection has risen steadily over the past year, according to data presented this week.

  • PrEP
    Targeting PrEP to High-Risk Gays Would Lower HIV - For a Huge Price
    AIDSMeds | 22 hours ago

    Targeting Truvada as PrEP to New York City men who have sex with men at high risk for HIV is the most cost-effective approach to promoting the intervention.

  • Health services and systems
    Zimbabwe government to scale up anti-retroviral therapy services
    Key Correspondents | 22 hours ago

    Wallace Mawire reports from Zimbabwe on the Ministry of Health and Child Care's plans to scale up anti-retroviral therapy services by the end of 2014, amid concerns over the current huge deficit.

  • Policy
    Ebola responders look to lessons from HIV
    The Hill | 22 hours ago

    As the Ebola crisis deepens in West Africa, health leaders are taking cues from the international response to another deadly virus that has ravaged the continent — HIV.

  • Epidemiology and behaviour
    STIs and Hep C levels at all-time high in Australia
    Gay News Network | 22 hours ago

    The Kirby Institute’s Annual Surveillance Report suggests a number of STIs are continuing to increase, with syphilis and gonorrhoea leading the charge. Hepatitis C infections are also a growing health issue with more people now dying from viral hepatitis infection than from HIV when it was in its peak in the 80s and 90s.

  • Hepatitis C treatment
    Thousands register for new hepatitis C drug in Egypt sold at 99 percent discount
    Egyptian Streets | 19 September 2014

    On Thursday, Gamal Esmat, member of the Egyptian National Committee on Viral Hepatitis told Aswat Masriya that around 1,7000 people had registered hours after online registration opened on the Health Ministry’s website.

← First12345...941Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.